JP2005532378A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532378A5
JP2005532378A5 JP2004518565A JP2004518565A JP2005532378A5 JP 2005532378 A5 JP2005532378 A5 JP 2005532378A5 JP 2004518565 A JP2004518565 A JP 2004518565A JP 2004518565 A JP2004518565 A JP 2004518565A JP 2005532378 A5 JP2005532378 A5 JP 2005532378A5
Authority
JP
Japan
Prior art keywords
alkyl group
group
acid
methyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004518565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532378A (ja
Filing date
Publication date
Priority claimed from DE10230750A external-priority patent/DE10230750A1/de
Application filed filed Critical
Publication of JP2005532378A publication Critical patent/JP2005532378A/ja
Publication of JP2005532378A5 publication Critical patent/JP2005532378A5/ja
Pending legal-status Critical Current

Links

JP2004518565A 2002-07-09 2003-06-25 新規な抗コリン作動薬およびnk1レセプタアンタゴニストを含む新規な医薬組成物 Pending JP2005532378A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10230750A DE10230750A1 (de) 2002-07-09 2002-07-09 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
PCT/EP2003/006667 WO2004004724A1 (de) 2002-07-09 2003-06-25 Neue arzneimittelkompositionen auf der basis neuer anticholinergika und nk1-rezeptor-antagonisten

Publications (2)

Publication Number Publication Date
JP2005532378A JP2005532378A (ja) 2005-10-27
JP2005532378A5 true JP2005532378A5 (enExample) 2006-08-17

Family

ID=29761745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004518565A Pending JP2005532378A (ja) 2002-07-09 2003-06-25 新規な抗コリン作動薬およびnk1レセプタアンタゴニストを含む新規な医薬組成物

Country Status (6)

Country Link
EP (1) EP1521580A1 (enExample)
JP (1) JP2005532378A (enExample)
AU (1) AU2003242754A1 (enExample)
CA (1) CA2491451A1 (enExample)
DE (1) DE10230750A1 (enExample)
WO (1) WO2004004724A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070203139A1 (en) * 2004-04-14 2007-08-30 Astrazeneca Ab Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449590B (en) * 1995-04-14 2001-08-11 Boehringer Ingelheim Kg New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
DE19608665A1 (de) * 1996-03-06 1997-09-11 Boehringer Ingelheim Kg Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10051320A1 (de) * 2000-10-17 2002-04-25 Boehringer Ingelheim Pharma Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
US20040058914A1 (en) * 2000-12-22 2004-03-25 Takayuki Doi Combination drugs

Similar Documents

Publication Publication Date Title
ES2581834T3 (es) Formulación tópica para un inhibidor de JAK
JP7546027B2 (ja) ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
CA2531847C (en) Hfc solution formulations containing an anticholinergic
EP3093018B1 (en) Pharmaceutical preparation including pyridylamino acetic acid compound
JP2014037426A5 (enExample)
CA2481468A1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
TW201609097A (zh) 含吡啶基胺基乙酸化合物之醫藥組成物
JP6618736B2 (ja) ミラベグロン含有錠剤、ミラベグロン含有製剤の製造方法及びミラベグロン含有造粒物の製造方法
JP5081158B2 (ja) 呼吸器系疾患治療用の新規な医薬組成物
KR20160060656A (ko) 폴리에틸렌글리콜 함유 조성물
JP2005532378A5 (enExample)
US20120220557A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug
JP2005532379A5 (enExample)
JP2025111828A (ja) シロリムスまたはその塩を含有する水性懸濁組成物
JP2004519484A5 (enExample)
JP2005537250A5 (enExample)
JP2005517039A5 (enExample)
WO2016042493A1 (en) Pharmaceutical compositions of fingolimod
TW201113022A (en) Composition for ocular local-administration for treating ocular hypertension and glaucoma
CA2441964A1 (en) New pharmaceutical compositions based on anticholinergics and endothelin antagonists
AU2018354431A1 (en) Dosage regimen of paliperidone palmitate extended-release injectable suspension
RU2777552C2 (ru) Способ введения суспензии палиперидона пальмитата для инъекций с пролонгированным высвобождением
JP2025541009A (ja) ヒヨスチアミンを含む半フッ化アルカン組成物
JP2009504603A (ja) チオトロピウム塩とサルメテロールの塩とを組合せて投与する呼吸困難の治療方法
JP2025024082A (ja) ヘテロシクリデンアセトアミド誘導体を含む配合剤